SenzaGen Overview

  • Founded
  • 2010
Founded
  • Status
  • Public
  • Employees
  • 23
Employees
  • Stock Symbol
  • SENZA
Stock Symbol
  • Share Price
  • $1.67
  • (As of Friday Closing)

SenzaGen General Information

Description

SenzaGen AB markets, sells and performs the in vitro Genomic Allergen Rapid Detection (GARD) sensitization test through its own laboratory and through licensed Contract Research Organization (CROs) in Sweden. It offers animal-free testing of chemical compounds in cosmetics, pharmaceuticals, food products and dyes.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Laboratory Services (Healthcare)
Stock Exchange
STO
Primary Office
  • Medicon Village, Building 401
  • Scheelevägen 2
  • 223 81 Lund
  • Sweden
+46 046-275 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

SenzaGen Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.67 $1.56 $1.33 - $3.01 $35.6M 21.4M 18.6K -$0.15

SenzaGen Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 35,434 23,228 31,380 47,758
Revenue 1,065 863 288 230
EBITDA (3,281) (2,524) (3,692) (2,230)
Net Income (3,283) (2,947) (5,311) (1,849)
Total Assets 11,472 13,598 15,290 10,065
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

SenzaGen Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore SenzaGen‘s full profile, request access.

Request a free trial

SenzaGen Executive Team (5)

Name Title Board Seat Contact Info
Axel Sjöblad Chief Executive Officer
Brian Rogers Ph.D Chief Executive Officer of US Operation
Marianne Olsson Vice President of Finance
You’re viewing 3 of 5 executive team members. Get the full list »

SenzaGen Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SenzaGen Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore SenzaGen‘s full profile, request access.

Request a free trial